The human eye may literally become a window revealing the earliest signals of Alzheimer's disease, thanks to a new federally funded research initiative at Oregon Health & Science University. The new ...

OHSU scientist Lei Wang, Ph.D., is part of a new federally funded initiative to develop an eye scan to detect early screening for Alzheimer’s disease. Wang, an organic chemist by training, is ...

"What started as something asymptomatic for the majority of my life turned into a lingering cough, which turned to chest pains, bouts of coughing up blood, then at times, struggling to breathe," she ...

Leber Congenital Amaurosis (LCA) is an inherited retinal disease leading to severe vision impairment from early infancy, affecting 2-3 out of every 100,000 newborns. LCA is caused by variants in ...

MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the program to Eli Lilly in a deal potentially worth more than $475 million. The ...

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of OPGx-LCA5 First participant enrolled in run-in period for ...

Amazon announced a slew of 2K and 4K doorbells and cameras during its fall hardware event. Amazon announced a slew of 2K and 4K doorbells and cameras during its fall hardware event. is a senior ...

About 1 in 20 people who have had a laser procedure to patch a retinal tear will have another retinal tear or, worse, a retinal detachment after they have cataract surgery, an analysis of a large ...

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer's disease. In a new study ...

Scientists have developed new tools to improve gene therapy in advanced stages of inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis. Inherited retinal ...

A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data from all three patients anticipated in Q3 2025 FDA Type D meeting ...

MeiraGTx Holdings plc announced promising results from a first-in-human study published in The Lancet, involving a gene therapy treatment for children with AIPL1-associated retinal dystrophy, ...